Boston Scientific (BSX) Other Accumulated Expenses (2009 - 2026)

Boston Scientific's Other Accumulated Expenses history runs 18 years deep, the most recent figure standing at $875.0 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 5.2% year-over-year to $875.0 million; the TTM figure through Mar 2026 stood at $875.0 million (down 5.2% YoY), while the FY2025 annual figure was $795.0 million, down 10.37% from the prior year.
• Other Accumulated Expenses came in at $875.0 million for Q1 2026 at Boston Scientific, up from $795.0 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $1.0 billion in Q1 2022 to a low of $752.0 million in Q3 2022.
• A 5-year average of $855.1 million and a median of $862.0 million in 2025 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses jumped 46.67% in 2022 and fell 23.89% in 2023, its largest moves.
• Boston Scientific's Other Accumulated Expenses stood at $761.0 million in 2022, then advanced by 6.96% to $814.0 million in 2023, then climbed by 8.97% to $887.0 million in 2024, then decreased by 10.37% to $795.0 million in 2025, then climbed by 10.06% to $875.0 million in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $875.0 million, $795.0 million, and $862.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison